What Happened?
Shares of global pharmaceutical company Eli Lilly (NYSE: LLY) jumped 4.7% in the afternoon session after the FDA approved Foundayo (orforglipron), its highly anticipated once-daily oral weight loss pill.
Foundayo offers a needle-free alternative for obesity management without the strict fasting or water restrictions that hamper competing oral GLP-1s. Beyond the "weight-loss win," investor confidence was boosted by Lilly's $7.8 billion acquisition of Centessa Pharmaceuticals. This pivot into the neuroscience and sleep-wake disorder market demonstrates a proactive effort to diversify revenue and reduce long-term reliance on metabolic health.
After the initial pop the shares cooled down to $960.75, up 4.5% from previous close.
Is now the time to buy Eli Lilly? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Eli Lilly’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 15 days ago when the stock dropped 6.3% on the news that investment bank HSBC downgraded the stock to a sell-equivalent "reduce" rating from "hold," citing concerns that its shares were "priced to perfection.".
The bank's analyst, Rajesh Kumar, also lowered the price target to $850 from $1,070. The downgrade stemmed from a belief that the total market for obesity drugs might be smaller than many analysts forecasted and that future price competition for blockbuster drugs like Zepbound was likely to be significant. HSBC noted that expectations for Eli Lilly's upcoming oral weight-loss pill were also too high.
Eli Lilly is down 11.1% since the beginning of the year, and at $960.75 per share, it is trading 13.4% below its 52-week high of $1,110 from November 2025. Despite the year-to-date decline, investors who bought $1,000 worth of Eli Lilly’s shares 5 years ago would now be looking at an investment worth $5,187.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
